Not recommended for pregnant or breastfeeding women
This metabolic overlap has led some patients and clinicians to wonder whether medications targeting metabolic pathways, such as GLP-1 receptor agonists, might offer benefits for individuals with Hashimoto's disease
Additional information Gustavo C
The article states that these peptide molecules are too large and too rapidly metabolised to accumulate in standard serum assays, and that clinical labs do not routinely test for their presence at all
Kathleen Valenton, MD, Lemme advisory board member, also shared this: "Lemme GLP-1 Daily is formulated with safe ingredients with no known side effects
If you are considering switching from semaglutide to tirzepatide, working with an experienced provider can help you determine the safest and most effective treatment plan for your goals